Company
DenmarkPublic company, NYSE: NVONovo Nordisk A/S (NYSE: NVO), Hjorring, Denmark – FDA Inspections
Inspection records and compliance data for Novo Nordisk A/S in Hjorring. 1 FDA inspection on record, last inspected March 21, 2013. Publicly traded as NYSE: NVO.
Company Profile
This profile covers Novo Nordisk A/S based in Hjorring, Denmark.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Form 483s
- 0
- Warning letters
- 0
Inspected March 21, 2013.
Most cited issue areas
- Procedures for product review,disposition lack of/inadequate1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 21, 2013 | VAI | Medical Devices & Rad Health · Compliance: Devices | 830061 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Novo Nordisk A/S
Stock ticker
NVO
Exchange
NYSE
Share price
$40.66
Market cap
$180.0B
Price as of
November 13, 2026
FEI Number
3004547341
Address
Stenager Alle, Hjorring, Denmark
Country
Denmark
ID: 030db069-624c-430f-97ef-6206f5912a96